Peer-influenced content. Sources you trust. No registration required. This is HCN.
The Epoch Times
Recent research from Brown University suggests that the SARS-CoV-2 spike protein could interfere with cancer treatment efficacy by affecting the p53 gene’s ability to suppress tumor growth and repair DNA.
Allergy & Immunology May 1st 2024
OBR Oncology
Physicians are urged to reevaluate their approach to charity engagement following a lawsuit alleging diversion of donations from cancer patients to for-profit fundraisers and operators.
Hematology/Oncology April 29th 2024
Healthcare professionals must prioritize compliance with billing and documentation standards to navigate heightened regulatory scrutiny in oncology.
Understanding liver cancer’s complexities is crucial in guiding patients towards effective treatment and preventive measures. This overview sheds light on the pivotal aspects of managing liver cancer, from symptoms to therapy options.
Hepatology April 29th 2024
The New England Journal of Medicine
In a recent study involving patients with CD7-positive leukemia and lymphoma, an integrated approach of CAR T-cell therapy followed by haploidentical HSCT resulted in a one-year disease-free survival rate of 54%. This strategy highlights the potential for advanced therapeutic combinations to manage relapsed or refractory hematologic cancers effectively.
“In light of recent findings, it is crucial to evaluate the implications of modified mRNA in therapeutic uses, particularly its role in immune response and potential cancer progression.”
Allergy & Immunology April 29th 2024